Next |
home / stock / cdna / cdna message board
Subject | By | Source | When |
---|---|---|---|
$CDNA short data if anyone is interested | Porterhouse10 | investorshub | 07/04/2023 6:51:12 AM |
MomentumIts gaining | ClayTrader | investorshub | 06/28/2023 8:06:47 AM |
Price trading | stocktrademan | investorshub | 06/26/2023 1:57:02 AM |
$CDNA got some short data | stocktrademan | investorshub | 06/25/2023 12:04:58 PM |
The trading | TREND1 | investorshub | 06/24/2023 10:05:41 PM |
$CDNA Price now up | gregque | investorshub | 06/22/2023 12:01:42 AM |
got some short data | TREND1 | investorshub | 06/20/2023 7:28:43 PM |
$CDNA The now | TREND1 | investorshub | 06/19/2023 1:53:41 PM |
MomentumIts gaining last trade up | ClayTrader | investorshub | 06/18/2023 2:17:43 PM |
here we go bulls news is here | Yo-Yo | investorshub | 06/17/2023 8:18:51 PM |
$CDNA Do we have a winner?Turn around time? | Tdash | investorshub | 06/15/2023 8:17:57 PM |
Cathy Woods is | Porterhouse10 | investorshub | 10/26/2022 12:16:34 AM |
Anybody playing ? CDNA!!! | Yo-Yo | investorshub | 03/23/2018 10:10:24 PM |
Float = 17.25M | TREND1 | investorshub | 11/23/2017 7:12:56 PM |
Profit/Loss = $ -39.47M | TREND1 | investorshub | 11/23/2017 7:11:56 PM |
CareDx, Inc. (Nasdaq:$CDNA), a molecular diagnostics company focused | TREND1 | investorshub | 11/23/2017 7:10:50 PM |
$CDNA | TREND1 | investorshub | 11/23/2017 7:08:31 PM |
im n this looks good next qtr. should | gregque | investorshub | 10/05/2017 6:40:29 PM |
Here we go!!! | Jess070283 | investorshub | 10/05/2017 1:28:56 PM |
* * $CDNA Video Chart 09-26-17 * * | ClayTrader | investorshub | 09/26/2017 9:10:12 PM |
News, Short Squeeze, Breakout and More Instantly...
CareDx Inc. Company Name:
CDNA Stock Symbol:
NASDAQ Market:
AI-Derived AlloView Results Correlate with Presence and Type of Biopsy Proven Kidney Rejection Longitudinal Monitoring with AlloSure Kidney Enables Earlier Identification of Graft Injury and Assessment of Rejection Treatment KOAR Data Show Kidney Biopsies Informed by AlloSure Dete...
CareDx Reiterates Position that it Does Not Infringe Natera’s ‘544 Patent Injunction Motion has No Impact on CareDx’s Business or Patient and Clinician Access to AlloSure or AlloMap CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused ...
As of May 24, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in th...